Monday, January 8, 2018
Home »
business news
» Celgene to buy Impact Biomedicines for up to $7B
Celgene to buy Impact Biomedicines for up to $7B
Celgene to buy Impact Biomedicines for up to $7B
U.S. biotech pharmaceutical firm Celgene Corp said on Sunday that it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance.
Interest rates held at 5% but 'on the path down'
Economists are betting on rates being held in September with a cut to come in November instead. from BBC News https://ift.tt/OyPldkf
0 comments:
Post a Comment